相关实验视频
Updated: Jul 25, 2025

07:51
Video Movement Analysis Using Smartphones ViMAS: A Pilot Study
Published on: March 14, 2017
16.9K
一个智能手机应用程序的联合生产和可用性,用于在帕金森病中报告布
Jill Wales1, Jason Moore2, Jenni Naisby1
1Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle-upon-Tyne, UK.
Physical therapy
|June 27, 2023
概括
研究人员开发了iFall应用程序,这是一个智能手机工具,用于报告帕金森病 (PD) 患者的跌倒情况. 这款易于使用的应用程序支持自我管理,可以集成到临床护理和研究中.
科学领域:
- 神经学 神经学
- 数字健康数字健康
- 人与计算机的交互
背景情况:
- 帕金森病 (PD) 在布管理方面带来了挑战.
- 数字工具正在出现,用于患者自我管理和数据收集.
- 与患者共同设计技术可以确保相关性和可用性.
研究的目的:
- 共同开发智能手机应用程序,用于在帕金森病 (PD) 患者中进行数字跌倒报告.
- 评估开发的应用程序在患有PD的人群中的可用性.
主要方法:
- 采用了三阶段的方法:与PD共同研究人员一起开发应用程序,与15名PD参与者进行可用性测试,并通过使用系统可用性量表的重点小组进行评估.
- 该应用程序的开发涉及研究人员,一个项目咨询小组,和PD患者超过六个月.
- 用户可用性由10名PD患者在两个重点小组中评估.
主要成果:
- 成功开发了iFall应用程序的功能原型.
- 该应用得到了PD患者的良好可用性评分 (75.8%).
- 确定的关键主题包括应用程序可用性,降落管理增强和未来开发建议.
结论:
- iFall应用程序原型是PD患者的用户友好的数字工具.
- 该应用程序显示了作为PD患者自我管理工具的潜力.
- 它可以整合到临床实践和研究中,用于跌倒和近乎失误报告.
相关概念视频
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
Parkinson's Disease: Overview
607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607

